Results 161 to 170 of about 68,269 (251)

Intratumoral Microbiota in Tumor: Current Understandings and Future Perspectives

MedComm, Volume 7, Issue 7, July 2026.
Intratumoral bacteria are emerging as active regulators of cancer evolution rather than bystanders. This review outlines how tumor‐resident microbes drive tumor initiation and growth by inducing genomic instability, epigenetic reprogramming, oncogenic signaling, and chronic inflammation, while promoting metastatic spread via invasion, angiogenesis ...
Jiawei Chen, Yupan Bai, Lu Shen, Jiacheng Ying, Jie Xu, Jiayin Tang, Yujie Bao   +6 more
wiley   +1 more source

The Multifaceted Role of Pyroptosis: Molecular Mechanisms, Crosstalk with Other Cell Death Pathways, and Therapeutic Implications

MedComm, Volume 7, Issue 7, July 2026.
Pyroptosis maintains immune homeostasis by eliminating damaged or infected cells, but its dysregulation promotes inflammation and cancer progression. The diagram illustrates key activation pathways, links with other programmed cell deaths, and cancer‐specific effects, enhancing its dual protective and pathogenic roles.
Diego Liviu Boaru, Patricia De Castro‐Martinez, Cielo Garcia‐Montero, Oscar Fraile‐Martinez, Majd N. Michael Alhaddadin, Silvestra Barrena‐Blázquez, Laura Lopez‐Gonzalez, Clara Tasende Fernández, Ricardo Alvarado‐Hurtado, Tomás Ratia Giménez, Inmaculada Lasa‐Unzúe, Manuel Díez Alonso, Alberto Gutiérrez‐Calvo, Miguel A. Saez, David Cobo‐Prieto, Jose V. Saz, Melchor Alvarez‐Mon, Raul Diaz‐Pedrero, Miguel A. Ortega   +18 more
wiley   +1 more source

Urologic Bacteriome: The Hero or the Villain in Prostate Cancer Onset, Progression, and Treatment?

Medicinal Research Reviews, Volume 46, Issue 4, Page 1111-1151, July 2026.
ABSTRACT Prostate cancer (PCa) is the second most frequently diagnosed cancer in men worldwide and the fifth leading cause of cancer‐related mortality, presenting urgent unmet clinical needs in diagnosis and treatment. The recognition of the microbiome as a key factor in human health has prompted numerous studies, revealing an exciting new approach to ...
Lara R. S. Fonseca, Mariana Feijó, Cátia V. Vaz, Bruno J. Pereira, Sandra Laurentino, Ana Palmeira‐de‐Oliveira, Sílvia Socorro   +6 more
wiley   +1 more source

The Molecular Interplay Between Helicobacter pylori Infection and Ulcerative Colitis: Unraveling Shared Biomarkers and Pathway Networks. [PDF]

Immun Inflamm Dis
Zhu M, Li X, Huang X, Dong R, Zhang S.
europepmc   +1 more source

Exploring Antimicrobial Activities of Fixed Oil From Sanguisorba minor Seeds by In Vitro and In Silico Analysis

ChemistryOpen, Volume 15, Issue 7, July 2026.
The fixed oil from Sanguisorba minor Scop. seeds exhibits low antioxidant activity in DPPH• and ABTS+ assays, while it demonstrates high antimicrobial activity, with MBC (22.5 ‐ 45 μL/mL) and MFC (5.625 ‐ 11.25 μL/mL) values. Linoleic acid (43.26%), α‐linolenic acid (25.31%), and oleic acid (20.73%), identified by GC‐MS as the main fatty acids, are ...
Zehra Torun, Tuba Unver, Harun Uslu, Bunyamin Goktas   +3 more
wiley   +1 more source

Interaction Between Metabolic Diseases, GLP-1 Receptor Agonists, and Helicobacter pylori Infection: An Updated Evidence Summary. [PDF]

Korean J Helicobacter Up Gastrointest Res
Lee JY.
europepmc   +1 more source

Metastatic Gastric Adenocarcinoma Presenting With Pleuropericardial Effusions and Cardiac Tamponade: A Diagnostic Challenging Case Report

Respirology Case Reports, Volume 14, Issue 7, July 2026.
This case highlights the diagnostic challenge of occult gastric adenocarcinoma presenting with pleuropericardial effusions and tamponade. In unexplained lymphocyte‐predominant effusions, malignancy should be considered, and early VATS‐guided pleural biopsy may be required when noninvasive tests are inconclusive.
Mahta Moradi, Mehdi Karimi, Pegah Babaheidarian, Seyed Arash Javad Moosavi, Samira Nakhaie, Reza Ghaderi   +5 more
wiley   +1 more source

Assessment of Salivary Polymerase Chain Reaction as a Non-invasive Method for Detecting Helicobacter pylori Infection in Patients With Symptomatic Gastritis. [PDF]

Cureus
Khan MS, Kak MM, Farooq S, Gupta S.
europepmc   +1 more source

The Associations Between Acid‐Suppressive Drug Intake and Symptom Profiles in Functional Dyspepsia Patients Referred for Open‐Access Endoscopy

United European Gastroenterology Journal, Volume 14, Issue 6, July 2026.
ABSTRACT Background Functional dyspepsia (FD) is characterised by postprandial fullness, early satiation, epigastric pain, or burning without structural abnormalities on upper endoscopy. Proton pump inhibitors (PPIs) are the preferred first‐line therapy.
Scheepers Janne, Carbone Florencia, Matheussen Hanne, Van den Houte Karen, Tack Jan   +4 more
wiley   +1 more source